Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort study
Author:
Affiliation:
1. Division of Gastroenterology/Hepatology, Department of Medicine, Beth Israel Deaconess Medical Center; Harvard Medical School; Boston MA
Publisher
Wiley
Subject
Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.28416/fullpdf
Reference25 articles.
1. Persistent increase of prevalence of metabolic syndrome among US adults: NHANES III to NHANES 1999-2006;Mozumdar;Diabetes Care,2011
2. Burden of gastrointestinal disease in the United States: 2012 update;Peery;Gastroenterology,2012
3. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015
4. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?;Afdhal;JAMA,2012
5. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology,2012
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Health-related Quality of Life in Patients With Nonalcoholic Fatty Liver Disease: A Prospective Multi-center UK Study;Clinical Gastroenterology and Hepatology;2023-11
2. Long‐term follow‐up of web‐based and group‐based behavioural intervention in NAFLD in a real world clinical setting;Alimentary Pharmacology & Therapeutics;2023-10-16
3. Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID‐19 severity in patients with nonalcoholic fatty liver disease;Hepatology Research;2023-07-31
4. Improved health‐related quality of life with semaglutide in people with non‐alcoholic steatohepatitis: A randomised trial;Alimentary Pharmacology & Therapeutics;2023-06-16
5. Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease;Clinics in Liver Disease;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3